clinical trial · NCT03840993
Safety and Efficacy Study of MT-2990 in Women With Endometriosis
Tanabe Pharma America, Inc.·phase2·completed·n = 76
Endometrial Related PainMT-2990Placebo
brief summary
The purpose of this study is to assess the safety and efficacy of MT-2990 for treatment of moderate to severe endometriosis-related pain in women with surgically diagnosed endometriosis.
started
Jan 15, 2019
primary completion
May 13, 2021
completion
Oct 5, 2021
last updated
Dec 31, 2025
official title
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of MT-2990 in Women With Endometriosis Experiencing Endometrial Related Pain
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol